Tuesday, March 3, 2015

Actavis Megabond Deal Sees Strong Demand

Associated Press Actavis CEO Brenton Saunders, left, and Allergan CEO David Pyott posse for a photo on the floor of the New York Stock Exchange. The second largest corporate bond offering in history is underway as pharmaceutical company Actavis (ACT) issues $21 billion bonds Tuesday in 10 different maturities. The deal size is topped only [...]

No comments:

Post a Comment